PositiveID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

August 15, 2014
PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History
more
August 13, 2014
PositiveID Corporation to Exhibit at the 2014 Military Health System Research Symposium Conference on August 18-21
more
August 7, 2014
PositiveID's Firefly Dx System Featured on Fox News San Francisco
more
July 17, 2014
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
more
June 30, 2014
PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Company report

PositiveID and Secure Strategy Group have published a report on PositiveID. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2014 - All Rights Reserved